Literature DB >> 23962882

Using chemical shift perturbation to characterise ligand binding.

Mike P Williamson1.   

Abstract

Chemical shift perturbation (CSP, chemical shift mapping or complexation-induced changes in chemical shift, CIS) follows changes in the chemical shifts of a protein when a ligand is added, and uses these to determine the location of the binding site, the affinity of the ligand, and/or possibly the structure of the complex. A key factor in determining the appearance of spectra during a titration is the exchange rate between free and bound, or more specifically the off-rate koff. When koff is greater than the chemical shift difference between free and bound, which typically equates to an affinity Kd weaker than about 3μM, then exchange is fast on the chemical shift timescale. Under these circumstances, the observed shift is the population-weighted average of free and bound, which allows Kd to be determined from measurement of peak positions, provided the measurements are made appropriately. (1)H shifts are influenced to a large extent by through-space interactions, whereas (13)Cα and (13)Cβ shifts are influenced more by through-bond effects. (15)N and (13)C' shifts are influenced both by through-bond and by through-space (hydrogen bonding) interactions. For determining the location of a bound ligand on the basis of shift change, the most appropriate method is therefore usually to measure (15)N HSQC spectra, calculate the geometrical distance moved by the peak, weighting (15)N shifts by a factor of about 0.14 compared to (1)H shifts, and select those residues for which the weighted shift change is larger than the standard deviation of the shift for all residues. Other methods are discussed, in particular the measurement of (13)CH3 signals. Slow to intermediate exchange rates lead to line broadening, and make Kd values very difficult to obtain. There is no good way to distinguish changes in chemical shift due to direct binding of the ligand from changes in chemical shift due to allosteric change. Ligand binding at multiple sites can often be characterised, by simultaneous fitting of many measured shift changes, or more simply by adding substoichiometric amounts of ligand. The chemical shift changes can be used as restraints for docking ligand onto protein. By use of quantitative calculations of ligand-induced chemical shift changes, it is becoming possible to determine not just the position but also the orientation of ligands.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chemical shift; Dissociation constant; Docking; Exchange rate; Protein

Mesh:

Substances:

Year:  2013        PMID: 23962882     DOI: 10.1016/j.pnmrs.2013.02.001

Source DB:  PubMed          Journal:  Prog Nucl Magn Reson Spectrosc        ISSN: 0079-6565            Impact factor:   9.795


  437 in total

1.  The agouti-related peptide binds heparan sulfate through segments critical for its orexigenic effects.

Authors:  Rafael Palomino; Hsiau-Wei Lee; Glenn L Millhauser
Journal:  J Biol Chem       Date:  2017-03-06       Impact factor: 5.157

2.  Biophysical Studies of Bacterial Topoisomerases Substantiate Their Binding Modes to an Inhibitor.

Authors:  CongBao Kang; Yan Li; Joseph Cherian; Boping Liu; Hui Qi Ng; Michelle Yueqi Lee; Nur Huda Binte Ahmad; Zhi Ying Poh; Yun Xuan Wong; Qiwei Huang; Ying Lei Wong; Alvin W Hung; Jeffrey Hill; Thomas H Keller
Journal:  Biophys J       Date:  2015-11-03       Impact factor: 4.033

3.  Hydrogen/deuterium exchange memory NMR reveals structural epitopes involved in IgE cross-reactivity of allergenic lipid transfer proteins.

Authors:  Martina Di Muzio; Sabrina Wildner; Sara Huber; Michael Hauser; Eva Vejvar; Werner Auzinger; Christof Regl; Josef Laimer; Danila Zennaro; Nicole Wopfer; Christian G Huber; Ronald van Ree; Adriano Mari; Peter Lackner; Fatima Ferreira; Mario Schubert; Gabriele Gadermaier
Journal:  J Biol Chem       Date:  2020-12-18       Impact factor: 5.157

4.  Assessing the Structures and Interactions of γD-Crystallin Deamidation Variants.

Authors:  Alex J Guseman; Matthew J Whitley; Jeremy J González; Nityam Rathi; Mikayla Ambarian; Angela M Gronenborn
Journal:  Structure       Date:  2020-12-01       Impact factor: 5.006

5.  Nuclear Magnetic Resonance Insight into the Multiple Glycosaminoglycan Binding Modes of the Link Module from Human TSG-6.

Authors:  Younghee Park; Thomas A Jowitt; Anthony J Day; James H Prestegard
Journal:  Biochemistry       Date:  2016-01-06       Impact factor: 3.162

6.  Two fatty acid-binding proteins expressed in the intestine interact differently with endocannabinoids.

Authors:  May Poh Lai; Francine S Katz; Cédric Bernard; Judith Storch; Ruth E Stark
Journal:  Protein Sci       Date:  2020-04-28       Impact factor: 6.725

7.  Matching Protein Interfaces for Improved Medium-Chain Fatty Acid Production.

Authors:  Stephen Sarria; Thomas G Bartholow; Adam Verga; Michael D Burkart; Pamela Peralta-Yahya
Journal:  ACS Synth Biol       Date:  2018-05-03       Impact factor: 5.110

Review 8.  NMR-based investigations into target DNA search processes of proteins.

Authors:  Junji Iwahara; Levani Zandarashvili; Catherine A Kemme; Alexandre Esadze
Journal:  Methods       Date:  2018-05-10       Impact factor: 3.608

9.  Protein mimetic amyloid inhibitor potently abrogates cancer-associated mutant p53 aggregation and restores tumor suppressor function.

Authors:  L Palanikumar; Laura Karpauskaite; Mohamed Al-Sayegh; Ibrahim Chehade; Maheen Alam; Sarah Hassan; Debabrata Maity; Liaqat Ali; Mona Kalmouni; Yamanappa Hunashal; Jemil Ahmed; Tatiana Houhou; Shake Karapetyan; Zackary Falls; Ram Samudrala; Renu Pasricha; Gennaro Esposito; Ahmed J Afzal; Andrew D Hamilton; Sunil Kumar; Mazin Magzoub
Journal:  Nat Commun       Date:  2021-06-25       Impact factor: 14.919

10.  Structural analyses reveal the mechanism of inhibition of influenza virus NS1 by two antiviral compounds.

Authors:  Alex B Kleinpeter; Alexander S Jureka; Sally M Falahat; Todd J Green; Chad M Petit
Journal:  J Biol Chem       Date:  2018-08-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.